Search Results
Oct 19, 2025, 10:30 ET Subcutaneous amivantamab delivers promising 45 percent overall response rate with median duration of 7.2 months in recurrent or metastatic head and neck cancer
deletions or exon 21 L858R mutations.15†‡ Amivantamab-vmjw (RYBREVANT®) plus chemotherapy as a Category 1 recommendation for patients with locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R mutations who experienced
More news about: Johnson & Johnson
Oct 19, 2025, 08:45 ET SystImmune Announces iza-bren Meets One of the Dual Primary Endpoints in the BL-B01D1-303 Trial in Recurrent or Metastatic NPC Patients with Results Presented as a Late-Breaking Oral Presentation at ESMO
recurrent or metastatic NPC patients who had progressed after at least two prior lines of chemotherapy, including platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. These results were presented today in a late-breaking oral presentation at the 2025 European Society of Medical Oncology (ESMO) Congress.
More news about: SystImmune, Inc.
Oct 19, 2025, 07:32 ET 穿越都市與山野，LEPAS環球優雅駕控之旅全路況解鎖優雅出行
在上海市區路段，嘉賓重點體驗了城市油路和車輛起步加速，LEPAS L8平順的起步加速、寬敞的車內空間、舒適的座椅獲得了肯定，在音響系統的悠揚旋律中，詮釋了都市的摩登優雅。在駛往蘇州的高速路段，ACC自適應巡航等駕駛輔助功能全程護航，園林的清新與智能科技相得益彰。 在莫干山盤山公路上，LEPAS L8 精準的動力響應與轉向調校，從容應對複雜路況。在莫干山露營基地，車輛外放電功能為營地供電，車頂燈組點亮夜空，營造出溫暖而高級的戶外生活場景，試駕嘉賓在此圍坐交流，感受遠山的靜謐與自然之美，體驗優雅生活方式。
More news about: 奇瑞集團
Oct 19, 2025, 03:04 ET The 2025 Chery International User Summit Opens a New Chapter as AiMOGA Robotics Unveils Its Global Brand Strategy
intensive R&D, AiMOGA has successfully achieved a leap from L2 (collaborative-level) to L3 (assistance-level) capability — a key milestone in the journey toward higher-level intelligence. The realization of L3 capability provides the technical foundation for AiMOGA's positioning
More news about: Chery International
Oct 19, 2025, 02:00 ET Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia
(proteasome inhibitor, immunomodulatory agent, and CD38 monoclonal antibody). By the screening period, his serum free light chain level had reached 10,374.86 mg/L. The patient underwent two CAR-T cell infusions approximately two months apart: he first received low-dose lymphodepletion and a relatively lower dose
More news about: CARsgen Therapeutics
Oct 18, 2025, 23:55 ET Menuju Gaya Hidup Elegan -- "LEPAS Global Journey of Elegant Driving (China Stop)" Ditutup dengan Sukses
akurat membuat LEPAS L8 mudah dikendalikan. Saat berkemah, sumber daya listrik eksternal LEPAS L8 menerangi area perkemahan, menciptakan suasana hangat dan elegan di bawah cahaya malam. Saat melewati perbukitan berkabut di Xuancheng, stabilitas dan daya tahan LEPAS L8 mencerminkan ketenangan
More news about: Chery Group
Oct 18, 2025, 15:21 ET '바퀴'에서 '3차원 생태계'로: 2025 체리 글로벌 혁신 콘퍼런스, 지능형 모빌리티의 새로운 청사진 공개
미만의 응답 시간과 95%가 넘는 작업 정확도를 구현했다. 팔콘 900(Falcon 900) 지능형 주행 시스템은 VLA(비전•언어•행동) 학습과 세계 모델링(world modeling)을 통합해 완전한 안전 이중화를 갖춘 L3~L4 수준의 자율주행을 목표로 하고 있다. 선도적인 하이브리드 성능부터 인간 중심의 지능형 상호작용까지, 그리고 핵심 기술 혁신부터 전체 생태계 구축에 이르기까지, 체리는 28년간 쌓아온 기술적 노하우를 미래를 여는 열쇠로 전환하며
More news about: Chery International
Oct 18, 2025, 13:57 ET 優雅な人生への旅 -- LEPASエレガントドライビング・グローバルジャーニー（中国ステージ）が成功裏に終了
の幕開けを告げるものです。上海、蘇州、莫干山、宣城、蕪湖の全行程900km以上にわたって実施されたこの没入型試乗イベントでは、メディア、KOL、およびユーザーが参加し、LEPAS L8の優れた製品性能を体験しました。本イベントは、「エレガントなモビリティライフのための第一選択ブランド」というLEPASのブランドポジショニングを、壮大な走行体験とともに鮮やかに体現するものとなりました。
More news about: Chery Group
Oct 18, 2025, 13:55 ET 우아한 삶으로의 여정 -- 레파스 글로벌 우아한 주행 여정(중국 구간) 성료
Summit)에서 펼쳐질 레파스 브랜드 스토리의 서막을 알렸다. 상하이, 쑤저우, 모간산, 쉬안청, 우후를 가로지르는 900km 이상의 구간에서 진행된 이 몰입형 시승 행사에는 미디어, 인플루언서(KOL), 소비자 리더(KOC)도 함께 참여해 LEPAS L8의 탁월한 제품력을 체험했다. 행사는 우아한 주행을 전방위적으로 체험할 수 있는 쇼케이스이자 '우아한 모빌리티 라이프를 위한 선호 브랜드(Preferred Brand for Elegant Mobility Life)'라는 브랜드 포지셔닝을 생생하게 보여준
More news about: Chery Group
Oct 18, 2025, 13:45 ET Huawei Digital Power aiuta l'ASEAN a raggiungere una trasformazione a zero emissioni di carbonio con tecnologie di formazione della rete adatte a qualsiasi scenario
KUALA LUMPUR, Malesia, 18 ottobre 2025 /PRNewswire/ -- L' ASEAN Energy Business Forum (AEBF-25) si è tenuto a Kuala Lumpur, in Malesia, dal 15 al 17 ottobre, con il tema "Powering ASEAN: Bridging Boundaries,
More news about: Huawei
Oct 18, 2025, 13:09 ET Cesta za elegancí: Globální turné elegantního cestování LEPAS slavilo úspěch v Číně
Mo-kan-šan, Süan-čcheng a Wu-chu přilákala zástupce médií, významné osobnosti i zákazníky, aby se seznámili s výjimečnými přednostmi modelu LEPAS L8 a vychutnali si panoramatickou ukázku elegantní jízdy i živé ztvárnění image značky LEPAS jako „jedničky v elegantním cestování".
More news about: Chery Group
Oct 18, 2025, 13:06 ET Путешествие в элегантную жизнь -- международный автопробег LEPAS Global Journey of Elegant Driving (китайский этап) успешно завершен
тест-драйва, среди которых были представители СМИ, авторитетные блогеры и пользователи, смогли лично оценить выдающиеся характеристики электромобиля LEPAS L8 — впечатляющего образца стильного вождения и яркого воплощения позиционирования бренда как «предпочтительного выбора для жизни в стиле элегантной
More news about: Chery Group
Oct 18, 2025, 12:54 ET Huawei revela solução aprimorada de AI WAN com arquitetura centrada em IA para impulsionar o crescimento das operadoras
uma base de conhecimento com 300 mil casos. Para identificação de riscos, a MasOrange Spain implementou uma rede de condução autônoma IP de nível 4 (L4), impulsionada pela solução AI WAN da Huawei, reduzindo o tempo médio de reparo, reduzindo os custos e melhorando a eficiência operacional.
More news about: Huawei
Oct 18, 2025, 12:49 ET Huawei presenta una solución WAN con IA mejorada y una arquitectura centrada en la IA para impulsar el crecimiento de los operadores
uso de una base de conocimientos con 300.000 casos. Para la identificación de riesgos, MasOrange España implementó una red de conducción autónoma IP L4 impulsada por la solución WAN con IA de Huawei, lo que redujo el tiempo medio de reparación, a la vez que disminuyó los costos y mejoró la eficiencia.
More news about: Huawei
Oct 18, 2025, 12:36 ET Huawei представляет обновленное решение AI WAN с архитектурой, ориентированной на ИИ, для ускорения роста операторов связи
минут, используя базу знаний, насчитывающую 300 000 случаев. Для выявления рисков компания MasOrange Spain развернула автономную транспортную IP-сеть L4 на базе решения Huawei AI WAN, сократив среднее время ремонта при одновременном снижении затрат и повышении эффективности. Саммит
More news about: Huawei
Oct 18, 2025, 12:27 ET Huawei, Operatör Büyümesini Artırmak için Yapay Zeka Merkezli Mimariye Sahip Yükseltilmiş Yapay Zeka WAN Çözümünü Tanıttı
kullanarak arıza tespit süresini 45 dakikadan 5 dakikaya indirdi. MasOrange İspanya, risk tespiti için Huawei'in AI WAN Çözümü tarafından desteklenen bir L4 IP otonom sürüş ağı kurdu ve maliyetleri düşürüp verimliliği artırırken ortalama onarım süresini kısalttı. Zirve, 10'dan fazla
More news about: Huawei
Oct 18, 2025, 12:20 ET 화웨이, AI 중심 아키텍처 기반 업그레이드된 AI WAN 솔루션 공개....통신사 성장 가속화 기대
모바일 광둥(China Mobile Guangdong)은 30만 건 규모의 지식 데이터베이스를 활용해 진단 소요 시간을 45분에서 5분으로 단축했다. 위험 식별의 경우, 스페인 마스오렌지(MasOrange Spain)가 화웨이의 AI WAN 솔루션을 기반으로 구축된 L4 수준 IP 자율주행 네트워크(L4 IP Autonomous Driving Network)를 도입해 평균 복구 시간(MTTR)을 단축하고 비용 절감 및 효율성 향상을 동시에 달성했다. 이번 서밋은 Net5.5G 파이오니어 어워드(Net5.5G
More news about: Huawei
Oct 18, 2025, 10:30 ET PADCEV™ Plus KEYTRUDA™, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer
only. Consistent EFS and OS benefits were seen across all pre-defined subgroups, including age, gender, smoking status and PD-L1 status as well as protocol-defined stratification groups based on cisplatin ineligibility (ineligible vs eligible but declined), clinical stage and geographic
More news about: Astellas Pharma Inc.
Oct 18, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Oct 18, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EHang Holdings Limited - EH
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Oct 18, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amer Sports, Inc. - AS
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Oct 18, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reddit, Inc. - RDDT
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Oct 18, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Trinseo PLC - TSE
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Oct 18, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Brunello Cucinelli S.p.A. - BCUCY
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP
Oct 18, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz
More news about: Pomerantz LLP